94 related articles for article (PubMed ID: 11769733)
1. [Antisense RNA for urokinase receptor inhibits the invasiveness and metastasis of lung carcinoma].
Liao J; Xu S; Tang H; Lian F; Zhu Y
Zhonghua Bing Li Xue Za Zhi; 2001 Oct; 30(5):357-60. PubMed ID: 11769733
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines.
Lakka SS; Rajagopal R; Rajan MK; Mohan PM; Adachi Y; Dinh DH; Olivero WC; Gujrati M; Ali-Osman F; Roth JA; Yung WK; Kyritsis AP; Rao JS
Clin Cancer Res; 2001 Apr; 7(4):1087-93. PubMed ID: 11309361
[TBL] [Abstract][Full Text] [Related]
3. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
[TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS
Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of colon cancer metastasis by a 3'- end antisense urokinase receptor mRNA in a nude mouse model.
Wang Y; Liang X; Wu S; Murrell GA; Doe WF
Int J Cancer; 2001 Apr; 92(2):257-62. PubMed ID: 11291054
[TBL] [Abstract][Full Text] [Related]
6. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.
Kook YH; Adamski J; Zelent A; Ossowski L
EMBO J; 1994 Sep; 13(17):3983-91. PubMed ID: 8076594
[TBL] [Abstract][Full Text] [Related]
7. Analysis of expressions of components in the plasminogen activator system in high- and low-metastatic human lung cancer cells.
He C; He P; Liu LP; Zhu YS
J Cancer Res Clin Oncol; 2001; 127(3):180-6. PubMed ID: 11260863
[TBL] [Abstract][Full Text] [Related]
8. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
Mamoune A; Kassis J; Kharait S; Kloeker S; Manos E; Jones DA; Wells A
Exp Cell Res; 2004 Sep; 299(1):91-100. PubMed ID: 15302576
[TBL] [Abstract][Full Text] [Related]
9. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells.
Rao JS; Gondi C; Chetty C; Chittivelu S; Joseph PA; Lakka SS
Mol Cancer Ther; 2005 Sep; 4(9):1399-408. PubMed ID: 16170032
[TBL] [Abstract][Full Text] [Related]
11. Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy.
Yu W; Kim J; Ossowski L
J Cell Biol; 1997 May; 137(3):767-77. PubMed ID: 9151680
[TBL] [Abstract][Full Text] [Related]
12. Synergistic down-regulation of urokinase plasminogen activator receptor and matrix metalloproteinase-9 in SNB19 glioblastoma cells efficiently inhibits glioma cell invasion, angiogenesis, and tumor growth.
Lakka SS; Gondi CS; Yanamandra N; Dinh DH; Olivero WC; Gujrati M; Rao JS
Cancer Res; 2003 May; 63(10):2454-61. PubMed ID: 12750266
[TBL] [Abstract][Full Text] [Related]
13. Expression of antisense uPAR and antisense uPA from a bicistronic adenoviral construct inhibits glioma cell invasion, tumor growth, and angiogenesis.
Gondi CS; Lakka SS; Yanamandra N; Siddique K; Dinh DH; Olivero WC; Gujrati M; Rao JS
Oncogene; 2003 Sep; 22(38):5967-75. PubMed ID: 12955075
[TBL] [Abstract][Full Text] [Related]
14. [Establishment of urokinase receptor gene antisense RNA transfer system and its application in leukemia research].
Bai X; Fu JX; Xi XD; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):591-4. PubMed ID: 14706141
[TBL] [Abstract][Full Text] [Related]
15. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
Albo D; Berger DH; Rothman VL; Tuszynski GP
J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated expression of antisense urokinase plasminogen activator receptor and antisense cathepsin B inhibits tumor growth, invasion, and angiogenesis in gliomas.
Gondi CS; Lakka SS; Yanamandra N; Olivero WC; Dinh DH; Gujrati M; Tung CH; Weissleder R; Rao JS
Cancer Res; 2004 Jun; 64(12):4069-77. PubMed ID: 15205313
[TBL] [Abstract][Full Text] [Related]
17. Elevated urokinase-specific surface receptor expression is maintained through its interaction with urokinase plasminogen activator.
Mahanivong C; Yu J; Huang S
Mol Carcinog; 2007 Mar; 46(3):165-75. PubMed ID: 17186542
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the urokinase-type plasminogen activator receptor through inhibition of translation by antisense oligonucleotide suppresses invasion of human glioblastoma cells.
Mohan PM; Lakka SS; Mohanam S; Kin Y; Sawaya R; Kyritsis AP; Nicolson GL; Rao JS
Clin Exp Metastasis; 1999; 17(7):617-21. PubMed ID: 10845561
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice.
D'Alessio S; Margheri F; Pucci M; Del Rosso A; Monia BP; Bologna M; Leonetti C; Scarsella M; Zupi G; Fibbi G; Del Rosso M
Int J Cancer; 2004 May; 110(1):125-33. PubMed ID: 15054877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
